Live Pfizer updates | Page 12

Live Pfizer news coverage of developments with the latest updates. Stay on top of latest Pfizer news stories and find out what just happened, what is going on with Pfizer. The latest real-time news updates and headlines on Pfizer
Previous COVID infection may not protect you from new subvariant wave. Are you due for booster
Previous COVID infection may not protect you from new subvariant wave
Fox Chase Cancer Center and Sylvester Comprehensive Cancer Center Collaborate with Pfizer's Institute of Translational Equitable
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent Covid Vaccine Booster for Children 5 Through 11 Years
Second Pfizer/BioNTech bivalent Covid booster vaccine approved by UK medicines regulator
Should you really use your smartwatch or fitness wearable to monitor your heart?
Awards & Accolades 8 November
Which COVID vaccine you get can impact myocarditis risk
Chemist gets grant to study more RNA strands at once
Triglyceride-lowering trial neutral for cardiovascular event reduction
Research reveals Moderna's Covid vaccine safe and effective for young children
Rutgers Recruiting Participants for Pfizer Covid Pediatric Bivalent Vaccine Clinical Trial
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher
Pfizer's Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Dapagliflozin is not only clinically effective, but also cost effective in patients with chronic kidney disease
New control system for synthetic genes
Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus
Why Pregnant Women Shouldn't Wait to Get Flu Vaccinations and Covid Boosters
Stretchable battery packaging with moisture and gas barrier could power future of wearable devices
New study updates evidence on rare blood-clotting condition after Covid vaccination
Research updates evidence on rare blood-clotting condition after Covid vaccination
New NIIMBL Whitepaper Addresses Innovation for Today's Biopharma Talent Pipeline
New funding for Bridge Program
ATAGI recommendations for booster dose of paediatric Pfizer Covid vaccine in children aged 5
Budding pathologist untangling Covid vaccine response
King's study provides vital information to guide Covid vaccine development
NKF/TOS urge collaboration, clinical strategies to improve understanding of managing co-existing relationship between obesity
Secretary Blinken at Opening of New Philadelphia Passport Agency And
CDC Allows Novavax Monovalent Covid Boosters for Adults Ages 18 and Older
Third Covid vaccine dose is highly effective in patients with cirrhosis
Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022
Comparative safety of Pfizer-BioNTech Covid vaccine vs non-Covid vaccines in kids younger than age 5
Needs and challenges for Covid boosters and other vaccines in U.S
Thinking about bariatric surgery for weight loss?
U.S. COVID hospital admissions decline, patients less severely ill
Further pandemic support to Pacific
Gene associated with better immune response, protection after Covid vaccination
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster
Myocarditis seven times more likely with Covid than vaccines
CDC Expands Updated Covid Vaccines to Include Children Ages 5 Through 11
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent Covid Vaccine Booster
BioNTech chooses Melbourne for its Asia-Pacific mRNA R&D centre
MenACWY teenage meningitis vaccine programme drives herd immunity across all ages
UK Government injects funding boost for cutting-edge vaccine site in Darlington
Tofacitinib shows promise in scleroderma patients, researchers are optimistic for next phase of study
Tofacitinib reveals promise in scleroderma patients, researchers optimistic for next phase of study
Findings suggest Covid rebound not caused by impaired immune response
Researchers shed light on Covid booster dose effectiveness among elderly in Japan